|

Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes

RECRUITINGN/ASponsored by Hospital de Clinicas de Porto Alegre
Actively Recruiting
PhaseN/A
SponsorHospital de Clinicas de Porto Alegre
Started2022-09-06
Est. completion2025-03-30
Eligibility
Healthy vol.Accepted

Summary

Every year there is an increase in people with diabetes all over the world. Because it is a disease associated with several comorbidities and is increasing, there is a need for more effective treatments. Lifestyle changes combined with medication are the best strategies for the treatment and reduction of comorbidities. Therefore, the present study posits the hypothesis that the integration of nutritional education groups into standard treatment, within a nutrition-specialized outpatient clinic, may yield additional enhancements in health parameters among patients diagnosed with type 2 diabetes. The driving force behind this research lies in the pursuit of more effective strategies to enhance glycemic control, diminish the risk of complications, and elevate the overall quality of life for these patients. Our motivation stems from a commitment to base our interventions on scientific evidence and strive towards meaningful improvements in diabetes management outcomes. A randomized clinical trial will be conducted with adult patients with a previous diagnosis of type 2 diabetes. Patients will be divided into two groups (intervention: nutritional education added the usual care; and control: usual care). The outcomes analyzed will be: glycemic control, lipid profile, body mass and dynapenia obesity, blood pressure values, eating behavior, diabetes complications and adherence to recommendations.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

\- Adult patients with a previous diagnosis of type 2 diabetes mellitus

Exclusion Criteria:

* Patients with other types of diabetes
* With HbA1C within the therapeutic target or with values greater than 12%
* Severe neuropathy
* Chronic kidney disease \[glomerular filtration rate \<30mL/min/1.73m²\]
* Life expectancy \<6 months
* Chemical dependence/alcoholism or use of antipsychotics
* Autoimmune disease or chronic steroid use
* Gastroparesis
* Pregnant or lactating women
* Patients who have had an Episode of Acute Coronary Syndrome (ACS) in the last 60 days
* Wheelchair users
* Cognitive, neurological or psychiatric condition

Conditions2

DiabetesDiabetes Mellitus, Type 2

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.